Displaying 1–1 of 1 results for Ache Stokelman et al., Amgen Inc. and BioProcessors Corp

Sort By Relevance Sort By Date

Using PAT to Optimize Cell Culture for Monoclonal Antibody Development

(Whitepaper)

Ache Stokelman and colleagues on Amgen’s Global Process Science Team outline how they used BioProcessors Corp.’s SimCell platform to improve results.

Sort By Relevance Sort By Date